Showing results 6 to 9 of 9
Inhibition of SIRT6 potentiates the anti-tumor effect of doxorubicin through suppression of the DNA damage repair pathway in osteosarcoma Zhang, Zhongkai; Ha, Sang Hoon; Moon, Young Jae; Hussein, Usama Khamis; Song, Yiping; Kim, Kyoung Min; Park, See-Hyoung; et al, JOURNAL OF EXPERIMENTAL CLINICAL CANCER RESEARCH, v.39, no.1, 2020-11 |
Potential of L-thyroxine to differentiate osteoblast-like cells via Angiopoietin1 Park, See-Hyoung; Lee, Jongsung; Kang, Mi-Ae; Moon, Young Jae; Wang, Sung Il; Kim, Kyoung Min; Park, Byung-Hyun; et al, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, v.478, no.3, pp.1409 - 1415, 2016-09 |
SIRT6 Is Involved in the Progression of Ovarian Carcinomas via β-Catenin-Mediated Epithelial to Mesenchymal Transition Bae, Jun Sang; Noh, Sang Jae; Kim, Kyoung Min; Park, See-Hyoung; Hussein, Usama Khamis; Park, Ho Sung; Park, Byung-Hyun; et al, FRONTIERS IN ONCOLOGY, v.8, 2018-11 |
The PARP inhibitor olaparib potentiates the effect of the DNA damaging agent doxorubicin in osteosarcoma Park, Hye Jeong; Bae, Jun Sang; Kim, Kyoung Min; Moon, Young Jae; Park, See-Hyoung; Ha, Sang Hoon; Hussein, Usama Khamis; et al, JOURNAL OF EXPERIMENTAL CLINICAL CANCER RESEARCH, v.37, 2018-05 |
Discover